NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma
NCT03462316
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Bone Sarcoma
Soft Tissue Sarcoma
Interventions
BIOLOGICAL:
NY-ESO-1（TCR Affinity Enhancing Specific T cell Therapy）
Sponsor
Sun Yat-sen University
Collaborators
[object Object]